A subset of promoters bidirectionally expresses long non-coding RNAs (ncRNAs) of unknown function and protein-coding genes (PCGs) in parallel. Here, we define a set of 1107 highly conserved human bidirectional promoters that mediate the linked expression of long ncRNAs and PCGs. Depletion of the long ncRNA expressed from the RB1 promoter, ncRNA-RB1, reveals regulatory effects different from the RB1-controlled transcriptional program. ncRNA-RB1 positively regulates the expression of calreticulin (CALR) that in response to certain therapeutic interventions can translocate from the endoplasmic reticulum to the cell surface, hence activating anticancer immune responses. Knockdown of ncRNA-RB1 in tumor cells reduced expression of CALR, impaired the translocation of the protein to the cell surface upon treatment with anthracylines and consequently inhibited the cellular uptake by macrophages. In conclusion, co-transcription of ncRNA-RB1 and RB1 provides a positive link between the expression of the two tumor suppressors RB1 and the immune-relevant CALR protein. This regulatory interplay exemplifies disease-relevant co-regulation of two distinct gene products, in which loss of expression of one oncosuppressor protein entails the abolition of additional tumorinhibitory mechanisms.
INTRODUCTION
Several thousand long non-coding RNAs (ncRNAs), that is, functional RNA transcripts not encoding proteins, 1 are encoded in the human genome. 2, 3 These transcripts generally display low expression levels and high degrees of tissue specificity, suggesting catalytic roles in the regulation of gene expression. Long ncRNAs reportedly act on various levels of gene regulation mediating either activation or repression of target genes while interacting with a wide range of proteins. [4] [5] [6] [7] [8] Initially, long ncRNAs have been found to be involved in the recruitment of histone-modifying complexes to chromatin, which has recently been expanded by reports on the interaction of long ncRNAs with transcription factors and their importance during the formation of co-activator complexes. [7] [8] [9] Research has mostly been focused on the functional characterization of long ncRNAs originating from genomic regions that do not overlap with protein-coding genes (PCGs) and hence those transcripts that are expressed from independent promoters. 5, 6, 10, 11 Although many genome-wide studies in a wide range of organisms established that most PCG promoters are characterized by divergent non-coding transcription, the functional role of those promoter-associated long ncRNAs remains elusive. [12] [13] [14] [15] [16] In many cases, antisense transcripts upstream of promoters are unstable and their emergence might be explained by aberrant transcription initiation of RNA polymerase II due to the depletion of nucleosomes on active promoters. 14, [17] [18] [19] [20] In evolutionary terms, divergent transcription initiation could fuel the emergence of new functional genes, by exposing the transcribed DNA strand to mutagenic alterations as has been reported for the acquisition of splice sites. 21 Several studies have addressed the regulation of bidirectional transcription, 13, 16, 18, 19, [22] [23] [24] [25] [26] [27] with three of these shedding light on the functionality of ncRNAs that are bidirectionally expressed from human PCG promoters: Hung et al. 28 investigated human cell cycle-regulated genes and identified 58 functional long ncRNAs that are co-expressed with PCGs from bidirectional promoters. One of these transcripts, PANDA (P21 associated ncRNA DNA damage activated), is induced by DNA damage at the CDKN1A promoter and mediates regulation of pro-apoptotic genes. 28 In another study, human embryonic stem cells have been shown to robustly express more than 2000 long ncRNAs bidirectionally from within 2 kb of the transcription start sites (TSS) of PCGs. 16 Transcriptional activation of specific PCGs via the induction of cellular differentiation is coordinated with expression of paired long ncRNAs, suggesting similar functional roles for bidirectionally expressed genes. 16 Furthermore, the long ncRNA Fendrr that seems to be bidirectionally expressed from the Foxf1 promoter in mouse and partly co-expressed with the Foxf1 transcript has been shown to contribute to heart and body wall formation. 29 The coexpression of two genes from a bidirectional promoter suggests a mutual regulation mediated by a shared upstream transcriptional network, and implies that their functions might contribute to the same cellular response independently.
Cancer cells expose proteins at their cell surface, which differ from those of normal cells thereby serving as tumor antigens or activating signals for immune cells. 30, 31 One of the recently discovered 'eat-me' signals that are exposed on the cellular surface during instances of immunogenic cell death (ICD) is calreticulin (CALR). CALR is an endoplasmic reticulum sessile chaperone that in response to certain chemotherapeutic agents such as anthracyclines or oxaliplatin, translocates to the cellular surface in a pre-apoptotic manner. 32 Surface-exposed CALR then serves as a de novo uptake signal to phagocytic cells of the immune system. Thus, ICD can enable the eradication of chemotherapy-resistant cancer cells.
In this study, we used the GENCODE V19 annotation of the human genome to define a set of 1107 highly conserved bidirectional promoters driving the expression of long ncRNAs and PCGs. Most identified promoters are between 100 and 200 bp in length, indicating their potential of bidirectional transcription initiation, emphasizing the possibility of bidirectional expression driven by the same set of transcription factors. For a subset of these promoters we showed their potential to initiate bidirectional transcription. Furthermore, we addressed the function of ncRNA-RB1, a long ncRNA expressed from the RB1 promoter. Separate depletion of ncRNA-RB1 and RB1 mRNA demonstrated that the regulatory programs downstream of both genes contribute to tumor suppressor activity.
RESULTS
To investigate the relationship between divergently encoded long ncRNAs and PCGs in the human genome, we used the GENCODE V19 annotation. 3 We determined the distance between the TSSs of each annotated long ncRNA and its closest PCG encoded on the opposite DNA strand (Figures 1a and b ). 33 Within a region of 2 kb around the TSSs of PCG promoters, a promoter size that has previously been used to define PCG-associated long ncRNAs, we found 3891 long ncRNA/PCG pairs. 16 This set of long ncRNA/PCG pairs exhibits a major enrichment of promoters between 100 and 200 bp in length separating the TSSs ( Supplementary Figure 1) , which is in accordance with previous studies and supports the idea that most long ncRNAs in our data set share a promoter with their associated PCG rather than both genes being expressed from distinct promoters. 34 When filtering for bidirectional promoters of up to 500 bp in length, the set was narrowed down to nearly half (~45%) of the initial PCG-associated long ncRNAs. After removing overlapping genes, we recovered a final set of 1107 bidirectional ncRNA/PCG pairs (Figures 1a-c, Supplementary Table 1) .
Several cancer-related proteins are expressed from bidirectional ncRNA/PCG promoters, for example, the tumor suppressor retinoblastoma 1 (RB1), 35 Nuclear factor NF-kappa-B p100 subunit, 36 glycogen synthase kinase-3 beta 37 and Phosphatidylinositol 4,5-bisphosphate 3-kinase 38 (Supplementary Table 2 ). Consistently, previous analyses of bidirectional PCG/PCG pairs have shown that DNA-repair genes and genes implicated in somatic cancer are frequently expressed from bidirectional promoters, suggesting that such co-regulation is functionally important. 34, 39 Analysis of conservation of the candidate bidirectional ncRNA/ PCG promoters showed significantly higher conservation rates of bidirectional ncRNA/PCG promoters as compared with the average PCG promoter (P = 6.5 × 10 − 5 ; Figure 1d ), implying an evolutionary conservation of the genomic head-to-head arrangement of the 1107 candidate ncRNA/PCG pairs. This supports the notion that co-regulation of both paired genes is physiologically relevant.
To determine the potential of defined promoters to initiate bidirectional transcription, we tested four candidates (driving the expression of CCNG1, FKTN, MAGOH and RB1 genes) in a reporter assay. For the reporter assay the promoters were inserted into a vector containing firefly and Renilla reniformis luciferase genes in a head-to-head orientation to simultaneously measure the expression of both reporter genes (Figure 2a ). For all candidates, orientation of the promoter was directed so that firefly luciferase activity represents the promoter strength in the PCG direction and Renilla reniformis luciferase activity represents the promoter strength relevant to the long ncRNA expression. All tested promoters mediated high firefly luciferase activity, indicating their potential to initiate transcription of paired ncRNAs and PCGs ( Figure 2b ). Importantly, the four candidate bidirectional promoters more efficiently expressed Renilla reniformis luciferase than do two control promoters that appear predominantly unidirectional (GAPDH and TK; Figure 2b ). To determine the significance of this observation, we calculated the ratio between firefly and Renilla reniformis luciferase activities for all tested promoters. A value close to 1 implied a high bidirectional potential of a promoter, whereas potential unidirectional promoters were characterized by low values (CCNG1 = 0.30, FKTN = 0.22, MAGOH = 0.38, RB1 = 0.43, GAPDH = 0.01 and TK = 0.07). Importantly, the values for candidate bidirectional promoters were significantly higher than for control promoters (P ⩽ 0.001). Next, we determined relative transcript levels of three ncRNA/ PCG pairs across nine cell lines using quantitative reverse transcriptase (qRT)-PCR. For the CCNG1, PRKCQ and RB1 promoters, both transcripts were detectable in each of the cell lines examined. Expression levels for ncRNAs and respective mRNAs differed in several orders of magnitude and showed various degrees of correlation, as determined by calculating Pearson correlation coefficients (R CCNG1 = 0.86, R PRKCQ = 0.88, R RB1 = 0.41 (Figures 2c-e). A high correlation between endogenous ncRNA and PCG expression was observed for the CCNG1 and PRKCQ promoters, whereas the correlation for RB1 was less pronounced, potentially due to additional regulation of transcription and transcript stability.
Among the candidate promoters, the one driving expression of RB1 has been intensively studied. Within the RB1 promoter sequence, binding sites of at least five transcription factors that are responsible for regulated expression of the RB1 gene have been identified: ATF, 40 p53, 41 E2F1, 42 E4TF1 43 and Sp1 40 (Figure 3a ). ATF, SP1 and E4TF1 are activators of the RB1 gene, 40, 44, 45 and p53 and E2F1 (in complex with pRB1 itself) act as repressors. 41, 46 The TSSs of RB1 and ncRNA-RB1 are separated by a GC-rich 114-bp-long promoter region. As it is often observed in metazoan GC-rich promoters, the ncRNA-RB1/RB1 promoter lacks a TATA box, 47 further supporting the bidirectional nature of the region. Studies of the RB1 promoter have described that deletion of a 17-bp region overlapping the binding sites of SP1, ATF and E2F1 completely abrogates promoter activity in the RB1 direction. 44 We observed that this deletion not only reduces the promoter activity in the RB1 direction, but also decreased that in the ncRNA-RB1 direction, when introduced into the bidirectional luciferase vector (Figure 3b ). We further showed the co-regulation of transcription initiation by the RB1 promoter by introducing two distinct retinoblastoma-associated mutations into the Luciferase reporter, that are located within the ATF and SP1 transcription factor-binding sites. 40 Both point mutations dramatically reduced the bidirectional RB1 promoter activity, potentially also contributing to ncRNA-RB1 expression in vivo (Figure 3b ). ncRNA-RB1 is encoded by a 7.1-kb region 114 bp upstream of the RB1 gene. The transcript is annotated to consist of two isoforms with a maximum size of 1.14 kb (Figure 3c ). We determined the subcellular distribution of ncRNA-RB1 transcript levels by cellular fractionation of A549 cells followed by RNA isolation and qRT-PCR. This shows a predominantly nuclear localization of ncRNA-RB1 (Figure 3d ).
To gain insight into the regulatory functions of ncRNA-RB1 and to infer the involvement of this ncRNA within regulatory circuits of RB1, we individually depleted both transcripts from A549 cells using small interfering RNAs (siRNAs). Knockdown of both transcripts was efficient, yielding a 60-80 percent decrease of transcript levels (Figures 4a and d ). Furthermore, reduction in RB1 protein levels following knockdown of RB1 mRNA was confirmed by western blot analysis (Figure 4e ). When depleting ncRNA-RB1 no effects on RB1 transcript or protein levels were observed (Figures 4a, b and e). Likewise, depletion of RB1 mRNA did not affect the expression of ncRNA-RB1 ( Figures 4c and d) suggesting that the two transcripts do not regulate each other but rather contribute to independent regulatory functions. In order to identify targets of ncRNA-RB1 we performed RNAsequencing of poly(A)-enriched RNA from A549 cells after treatment with siRNAs against ncRNA-RB1. Cells depleted of RB1 were used for comparison of gene expression differences following knockdown of the two transcripts. The knockdown of ncRNA-RB1 resulted in differential expression of 200 genes that are not significantly enriched in any particular GO term (Figure 4f and Supplementary Table 3 ). The most highly regulated transcript in terms of absolute change in RPKM encodes the protein CALR (Figure 4g) , an endoplasmic reticulum-sessile chaperone that has been shown to be important for ICD by serving as an 'eat-me' signal presented by apoptotic cells. 30, 32 To further study the regulation of CALR by ncRNA-RB1, we monitored CALR protein levels following knockdown of ncRNA-RB1. Western blot analysis revealed a more than 80 percent reduction of CALR protein levels 48 h after siRNA-mediated knockdown of ncRNA-RB1, showing that the downregulation of CALR is pronounced also on the protein level (Figure 5a ). To determine whether the regulation of CALR by ncRNA-RB1 occurred on the transcriptional level, we subjected control or ncRNA-RB1-depleted cells to subcellular fractionation, and determined the abundance of CALR mRNA in chromatin-associated fractions (Figure 5b) . A significant decrease in CALR mRNA levels was observed in the chromatin fraction, suggesting a role of transcriptional regulation of CALR expression by ncRNA-RB1 (Figure 5b ). Decreased levels of ncRNA-RB1 were observable, although not statistically significant in the chromatin fraction, possibly because of the inefficient siRNA-mediated effects on chromatin (Figure 5c ). GAPDH levels on chromatin did not show any changes following knockdown of ncRNA-RB1 ( Figure 5d ). We further determined the subcellular distribution of CALR protein by immunofluorescence staining of control and ncRNA-RB1-depleted U2OS cells (Figure 6a ). These results are in accordance with the preponderant localization of CALR protein in the endoplasmic reticulum. 32 CALR reduction on the protein level by more than 60 percent was further quantified by cytofluorometric analysis (Figure 6b ).
Next, we addressed the functional impact of ncRNA-RB1 on CALR surface exposure and the potential effect on immunogenic cell removal. We therefore treated ncRNA-RB1-depleted U2OS cells with mitoxantrone (MTX), a chemotherapeutic agent that induces cell surface translocation of CALR. 32,48 CALR exposed at the cell membrane (ecto-CALR) was monitored by cell surface immunofluorescence staining of live cells followed by cytofluorometry. Ecto-CALR levels were strongly reduced upon depletion of ncRNA-RB1 as compared with control cells (Figures 6c and d) . As cell surface exposure of CALR is a major stimulus of phagocytosis, we hypothesized that a substantial decrease in ecto-CALR protein levels would interfere with a subsequent uptake by immune cells. Accordingly, as compared with controls, ncRNA-RB1 depletion resulted in reduced uptake of MTX-treated cells by human macrophages in an in vitro phagocytosis assay (Figures 6e and f) .
DISCUSSION
The functions of long ncRNAs that are associated with the promoters of PCGs remain mostly unclear, although this class of transcripts is increasingly detected in many genome-wide studies focusing on eukaryotic promoters. 12, 13, 16, 22, 23 Previous studies have proposed a role for PCG-associated antisense long ncRNAs in the direct regulation of their protein partner, for example, by interaction with the protein-coding DNA region or their complementary mRNA. 49, 50 In contrast to these findings, the RB1 promoter-associated long ncRNA-RB1 described in this study does not regulate the transcription of RB1. ncRNA-RB1 seems to mediate tumor-inhibitory mechanisms through the regulation of its target genes. The idea that co-transcription could entail co-functionality of paired gene products is supported by the observation that divergent PCG/PCG pairs in the human genome (around 10% of all PCGs) are enriched in specific functional categories, such as DNA repair and the regulation of cell cycle and metabolism. 51 As the annotated promoter region separating the TSSs of ncRNA-RB1 and RB1 is only 114 bp in size, we reasoned that the transcripts are likely to be co-expressed from a shared bidirectional promoter. Conceptually, the transcript pairs originating from relatively short bidirectional promoters should be regulated in a coordinated manner, as on nucleosome-free promoters the establishment of an active transcription environment on one TSS facilitates transcription initiation by polymerase II also at the divergent TSS. 20 The experimental validation of bidirectional promoter activity demonstrated the ability of the promoters to initiate transcription in both directions. Reduced bidirectional promoter activity upon introduction of single base pair mutations argues for a regulation by the same transcription factors and linked expression of the two transcripts. The high conservation rate we observed for the set of bidirectional ncRNA/PCG promoters further supports the importance of preservation of regulatory elements such as transcription factor-binding sites. The simultaneous transcription of long ncRNA/PCG pairs might be mediated by shared binding sites within the promoter region. Whereas the reporter assays for four candidate bidirectional promoters showed similar capabilities to mediate transcription in both directions, in vivo expression analysis for some of these endogenous promoters by qPCR showed a 100-fold difference between expression levels of long ncRNAs and PCGs for most cases. This suggests that further regulatory mechanisms are involved, affecting transcriptional elongation or posttranscriptional stability of both RNAs, which could also explain the low correlation in expression for some of the paired transcripts. The exosome has been suggested to be involved in the regulation of promoter-associated transcripts. 14 However, our attempts to demonstrate exosome involvement for selected long ncRNAs did not yield statistical significant differences.
The ncRNA-RB1 target gene CALR displayed the most pronounced differential expression in terms of absolute change in RPKM upon ncRNA-RB1 knockdown. The significance of this observation becomes clear when considering the high cellular abundance of this endoplasmic reticulum-sessile protein and its function as a major Ca 2+ -binding protein and chaperone. The CALR protein has been shown to serve as an 'eat-me' signal for immune cells when exposed to the plasma membrane. 30, 32, 48, 52 The transcriptional regulation of CALR by ncRNA-RB1 extended to the surface translocation of CALR observed upon MTX treatment. Whereas surface CALR was not directly affected by the knockdown of ncRNA-RB1, the translocation upon MTX treatment was markedly reduced. This difference in translocation was reflected in the reduced uptake of cancer cells by human macrophages, and thus assigns an important role to ncRNA-RB1 in the regulation of immunogenic cell removal. It has been proposed recently that tumorigenic cells are not only involved in disabling cell-intrinsic death programs (such as apoptosis) but they must also avoid programmed cell removal by phagocytes, a process that is also referred to as 'phagoptosis'. 30 One of the aims of chemotherapy is therefore to elicit an anticancer immune response by inducing the uptake of dying cancer cells by phagocytes.
In conclusion, we showed that ncRNA-RB1 links the transcription regulation of RB1 to expression of CALR and can mediate differential recognition of cancer cells by macrophages in ICD. The possibility that neoplastic cells can simultaneously abrogate expression of RB1 and ncRNA-RB1, caused by, for example, RB1 promoter mutation or hypermethylation, could have significant therapeutic relevance. ncRNA genes in general and PCGs were defined in the same way. For comparison, intergenic regions of 700 bp were extracted from random locations in the genome and masked for repetitive regions. Ten promoter sets of comparable size to the 1107 bidirectional promoters were considered for each of the other promoter classes and the results were averaged over 10 data sets. Position-wise conservation scores were computed from the PhastCons vertebrate conservation track from UCSC. 53 An average conservation score was then computed for each of the 700-bp regions, and the distribution of these scores plotted for each class.
MATERIALS AND METHODS

Promoter conservation analysis
Cell culture HEK293, A549 and U2OS cells were cultured in complete DMEM medium (Gibco/LifeTechnologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin (Gibco) at 37°C with 5% CO 2 .
Cloning of pGL3 reporter plasmids
The KpnI and MluI sites in the pGL3-Basic vector (Promega, Fitchburg, WI, USA) were used to insert the Renilla reniformis luciferase reporter gene amplified from the pRL-TK vector (Promega), yielding a head-to-head orientation of both reporter genes. Promoters were cloned into the BglII and HindIII restriction sites.
Primer sequences: Renilla Luciferase (5′-GGACGCGTCACTATAGGCTAG CCACCATGA-3′, 5′-GGGGTACCTGGATCCTTATCGATTTTACCA-3′), CCNG1 promoter (5′-GGAGATCTCAGCCGATTGACCTGACC-3′, 5′-GGAAGCTTGAGAC AACTCGGCCCTGAT-3′), FKTN promoter (5′-GGAGATCTGGTGAGGATGCGAC AAGAGT-3′, 5′-GGAAGCTTGAGCCTCCCGTACCTTACCT-3′), MAGOH promoter (5′-GGAGATCTTGCAGTCTTGTTGCCACTTC-3′, 5′-GGAAGCTTGCCTGAACT TCCAAGAGCAA-3′), RB1 promoter (5′-GGAAGCTTGCAACTGAGCGCCGC GTC-3′, 5′-GGAGATCTAGCGCCCCAGTTCCCCAC-3′). The TK promoter was exerted from the pRL-TK plasmid using BglII and HindIII restriction enzymes. England Biolabs (NEB), Ipswich, MA, USA). cDNA was synthesized using the High Capacity RNA-to-cDNA Kit (Life Technologies) and qPCR was performed using the Fast SYBR Green Master Mix (Life Technologies) on a 7900HT Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The relative expression was calculated by normalizing to the Actin expression level as reference control gene. The sequences of the real-time primers are: ncRNA-CCNG1 (5′-AGT GGTTCTGCCCCATCTTT-3′, 5′-GTGCTTTGAGAGGCCAAAGT-3′), CCNG1 mRNA (5′-TCACCTTCCAACAATTCCTGA-3′, 5′-AAGGTTGTGGAGAAAGGC TTC-3′), ncRNA-PRKCQ (5′-GGTGGGACTGCTTTCAACTT-3′, 5′-GCTGTTATCC GTTTGCCATT-3′), PRKCQ mRNA (5′-TGAGAGGTGCAGGAAGAACA-3′, 5′-GCC TTCCGTCTCAAATTCAT-3′), ncRNA-RB1 (5′-GGACGTGCTTCTACCCAGAAC-3′, 5′-TCCTTCTCAGTTGACGAGTTCA-3′) , RB1 (5′-GAGCAAGGTCTAAGGCAGGA-3′, 5′-CTGGCAGTTTGTTGCTTCAG-3′) and β-actin (5′-CGACAGGATGCAGA AGGAG-3′, 5′-GTACTTGCGCTCAGGAGGAG-3′).
Luciferase assay
RNA interference
dsiRNA oligos from IDTDNA (si1 ncRNA-RB1: sense 5′-GACGCUAAGUCAUG AGGAAUUAAAC-3′, antisense 5′-GUUUAAUUCCUCAUGACUUAGCGUCCC -3′; si2 ncRNA-RB1: sense 5′-CUGAACUCGUCAACUGAGAAGGAAA-3′, antisense 5′-UUUCCUUCUCAGUUGACGAGUUCAGAU-3′; si1 RB1: sense 5′-CUCCCAUGUUGCUCAAAGAACCATA-3′, antisense 5′-UAUGGUUCUUUGA GCAACAUGGGAGGU-3′) were used. As a negative control we used DS NC1 (IDT DNA).
Cells were transfected at a final dsiRNA concentration of 10 nM using Lipofectamine 2000 (Life Technologies) according to the manufacturer's protocol. Cells were collected 24 h post transfection for RNA isolation and 48 h post transfection for western blot analysis.
RNA isolation and sequencing
Total RNA was extracted using TRIzol (Life Technologies) and RNAseq libraries were prepared with the TruSeq RNA Sample Preparation Kit v2. Sequencing was performed on a HiSeq 2000 instrument (Illumina, San Diego, CA, USA) using paired-end sequencing (2 × 50 bp). Sequencing data were subjected to the quality control (QC) using defined metrics on an automated quality-control pipeline that combines published tools as FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) with in-house standardized methods. All reads that passed quality metrics were mapped to the latest human genome build (UCSC hg19). Sequencing duplicated reads were removed using PicardTools (http://picard.source forge.net/). For alignment the most recent version of Bowtie2 54 and TopHat2 55 were used. Read counting/summarizing was performed using Cufflinks2. 56 Immunoblotting Proteins were resolved using NuPAGE 4-12% Bis-Tris gels (Life Technologies) and 1X NuPAGE MOPS SDS Running Buffer (Life Technologies) and transferred onto PVDF membranes. Membranes were probed with a primary antibody (mouse anti-RB1 (4H1, Cell Signaling), mouse anti-CALR (FMC 75, Abcam), mouse anti-β-actin (8H10D10, Cell Signaling), mouse anti-α-tubulin (DM1A, Cell Signaling)).
Cellular fractionation
Cellular fractions for RNA isolation were prepared from~4 × 10 6 cells as described in 57 except for the proteinase K treatment of cytoplasmic and nuclear fractions.
Immunofluorescence
Ten thousand human osteosarcoma U2OS cells seeded in poly-L-lysinecoated 96-well Black/Clear Imaging Plates (BD Biosciences, Franklin Lakes, NJ, USA) were subjected to siRNA-mediated knockdown of ncRNA-RB1 as described above. Forty-eight hours later the cells were fixed with 3.7% paraformaldehyde (Sigma-Aldrich, St Louis, MO, USA) containing hoechst 33342 (Sigma-Aldrich), permeabilized with 0.1% triton-X100 and stained with anti-CALR antibody (Abcam, Cambridge, UK) for 30 min and subsequent Alexafluor-488-conjugated secondary antibody (Invitrogen, Carlsbad, CA, USA) diluted in blocking buffer (2% FBS, v/v in phosphatebuffered saline (PBS)). Nine view fields per well were acquired by means of a Molecular Devices IXM XL automated microscope and images were analyzed for cytoplasmic fluorescence intensity by using the Metaxpress software v. 5.1 (Molecular Devices, Sunnyvale, CA, USA).
Flow cytometry
Cells were collected, washed twice with PBS and thereafter incubated with anti-CALR antibody (Abcam) diluted in cold blocking buffer (2% FBS, v/v in PBS) for 30 min on ice, followed by washing and incubation with AlexaFluor 488 ® -conjugates (Invitrogen) in blocking buffer (for 30 min). Thereafter, cells were washed in cold PBS, PI was added to the final concentration of 1 μg/ml and samples were analyzed by means of a FACScan cytofluorometer (Becton Dickinson, Franklin Lakes, NJ, USA). Isotype-matched IgG antibodies (Cell Signaling Technology, Danvers, USA) were used as negative staining control, and the analysis was limited to living (PI − ) cells. Data were statistically evaluated by means of the Cell Quest Software package (Becton Dickinson).
Macrophage uptake assay
Peripheral blood mononuclear cells (PBMCs) were isolated from freshly harvested blood samples of healthy volunteers by means of Ficoll density gradient centrifugation. Macrophages were purified using a CD11bpositive selection (Miltenyi, Bergisch Gladbach, Germany) and labeled with CD11b-FITC antibody (Miltenyi) following the manufacturer's protocol. Fluorescein isothiocyanate (FITC)-labeled macrophages were incubated for 2 h at 37°C with orange cell tracker (Life technology)-stained U20S human osteosarcoma cells, that were subjected to siRNA-mediated knockdown of ncRNA-RB1 as described above and subsequently treated with 2 μM mitoxantrone for additional 12 h to induce CALR surface exposure. Cells were recovered and stained with the viability marker 4,6-diamidino-2phenylindole (Sigma) and immediately acquired on a Cyan ADP flow cytometer (Beckman Coulter, Brea, CA, USA). The uptake of apoptotic tumor cells stained with cell tracker orange by CD11b-FITC-positive macrophages was analyzed using the FlowJo software (Tree Star, Ashland, OR, USA).
Statistics
Experiments were carried out in minimally three independent replicates. Statistical analyses were performed using two-tailed Student's t-test.
